← All Phio Pharmaceuticals CORP filings

Phio Pharmaceuticals CORP Form 4 insider transactions

NASDAQ
PHIO
Phio Pharmaceuticals CORP
Form 4: Phio Pharmaceuticals CFO Acquires 8,000 Shares of Common Stock
Robert M. Infarinato, CFO of Phio Pharmaceuticals, reports the acquisition of 8,000 shares of common stock on August 13, 2024.
NASDAQ
PHIO
Phio Pharmaceuticals CORP
Form 4: Phio Pharmaceuticals CEO Acquires Additional Shares
Robert J. Bitterman, President and CEO of Phio Pharmaceuticals Corp., purchased 1,000 shares of common stock at $0.74 per share on June 7, 2024.
NASDAQ
PHIO
Phio Pharmaceuticals CORP
Form 4: Phio Pharmaceuticals CEO Acquires Additional Shares
Robert J. Bitterman, President & CEO of Phio Pharmaceuticals Corp., purchased 1,000 shares of common stock at $0.75 per share on June 6, 2024.
NASDAQ
PHIO
Phio Pharmaceuticals CORP
Form 4: Phio Pharmaceuticals Corp. Executive Caitlin Kontulis Reports Share Transaction
Caitlin Kontulis, Secretary & VP Finance & Admin of Phio Pharmaceuticals Corp., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
PHIO
Phio Pharmaceuticals CORP
Form 4: Phio Pharmaceuticals CEO Robert Bitterman Increases Stake in Company
Robert Bitterman, President & CEO of Phio Pharmaceuticals Corp., recently purchased 2,500 shares of common stock at $0.91 per share, increasing his total holdings.